BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11466354)

  • 1. Cross-linking of EphB6 resulting in signal transduction and apoptosis in Jurkat cells.
    Luo H; Wan X; Wu Y; Wu J
    J Immunol; 2001 Aug; 167(3):1362-70. PubMed ID: 11466354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-stimulation of T cells with CD2 augments TCR-CD3-mediated activation of protein tyrosine kinase p72syk, resulting in increased tyrosine phosphorylation of adapter proteins, Shc and Cbl.
    Umehara H; Huang JY; Kono T; Tabassam FH; Okazaki T; Gouda S; Nagano Y; Bloom ET; Domae N
    Int Immunol; 1998 Jun; 10(6):833-45. PubMed ID: 9678765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EphB6 crosslinking results in costimulation of T cells.
    Luo H; Yu G; Wu Y; Wu J
    J Clin Invest; 2002 Oct; 110(8):1141-50. PubMed ID: 12393850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kinase-null EphB6 receptor undergoes transphosphorylation in a complex with EphB1.
    Freywald A; Sharfe N; Roifman CM
    J Biol Chem; 2002 Feb; 277(6):3823-8. PubMed ID: 11713248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EphB6 receptor cooperates with c-Cbl to regulate the behavior of breast cancer cells.
    Truitt L; Freywald T; DeCoteau J; Sharfe N; Freywald A
    Cancer Res; 2010 Feb; 70(3):1141-53. PubMed ID: 20086179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A paradigm shift in EPH receptor interaction: biological relevance of EPHB6 interaction with EPHA2 and EPHB2 in breast carcinoma cell lines.
    Fox BP; Kandpal RP
    Cancer Genomics Proteomics; 2011; 8(4):185-93. PubMed ID: 21737611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phosphotyrosine phosphatase SHP-2 participates in a multimeric signaling complex and regulates T cell receptor (TCR) coupling to the Ras/mitogen-activated protein kinase (MAPK) pathway in Jurkat T cells.
    Frearson JA; Alexander DR
    J Exp Med; 1998 May; 187(9):1417-26. PubMed ID: 9565634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The EphB6 receptor inhibits JNK activation in T lymphocytes and modulates T cell receptor-mediated responses.
    Freywald A; Sharfe N; Rashotte C; Grunberger T; Roifman CM
    J Biol Chem; 2003 Mar; 278(12):10150-6. PubMed ID: 12517763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of liver-intestine cadherin (Cadherin 17) expression, ERK phosphorylation and WNT signaling in EPHB6 receptor-expressing MDA-MB-231 cells.
    Bhushan L; Tavitian N; Dey D; Tumur Z; Parsa C; Kandpal RP
    Cancer Genomics Proteomics; 2014; 11(5):239-49. PubMed ID: 25331796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ephrin-B2 is a candidate ligand for the Eph receptor, EphB6.
    Munthe E; Rian E; Holien T; Rasmussen A; Levy FO; Aasheim H
    FEBS Lett; 2000 Jan; 466(1):169-74. PubMed ID: 10648835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the EphB6 receptor ectodomain.
    Mason EO; Goldgur Y; Robev D; Freywald A; Nikolov DB; Himanen JP
    PLoS One; 2021; 16(3):e0247335. PubMed ID: 33770085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand stimulation induces clathrin- and Rab5-dependent downregulation of the kinase-dead EphB6 receptor preceded by the disruption of EphB6-Hsp90 interaction.
    Allonby O; El Zawily AM; Freywald T; Mousseau DD; Chlan J; Anderson D; Benmerah A; Sidhu V; Babu M; DeCoteau J; Freywald A
    Cell Signal; 2014 Dec; 26(12):2645-57. PubMed ID: 25152371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EphB6-null mutation results in compromised T cell function.
    Luo H; Yu G; Tremblay J; Wu J
    J Clin Invest; 2004 Dec; 114(12):1762-73. PubMed ID: 15599401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EphB6 Receptor: Kinase-Dead but Very Much Alive.
    Strozen TG; Sharpe JC; Harris ED; Uppalapati M; Toosi BM
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dancing with the dead: Eph receptors and their kinase-null partners.
    Truitt L; Freywald A
    Biochem Cell Biol; 2011 Apr; 89(2):115-29. PubMed ID: 21455264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C activation inhibits tyrosine phosphorylation of Cbl and its recruitment of Src homology 2 domain-containing proteins.
    Liu Y; Liu YC; Meller N; Giampa L; Elly C; Doyle M; Altman A
    J Immunol; 1999 Jun; 162(12):7095-101. PubMed ID: 10358153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell-specific expression of kinase-defective Eph-family receptor protein, EphB6 in normal as well as transformed hematopoietic cells.
    Shimoyama M; Matsuoka H; Tamekane A; Ito M; Iwata N; Inoue R; Chihara K; Furuya A; Hanai N; Matsui T
    Growth Factors; 2000; 18(1):63-78. PubMed ID: 10831073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I ligation of human T cells activates the ZAP70 and p56lck tyrosine kinases, leads to an alternative phenotype of the TCR/CD3 zeta-chain, and induces apoptosis.
    Skov S; Bregenholt S; Claesson MH
    J Immunol; 1997 Apr; 158(7):3189-96. PubMed ID: 9120273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor tyrosine kinase Ephb6 regulates vascular smooth muscle contractility and modulates blood pressure in concert with sex hormones.
    Luo H; Wu Z; Tremblay J; Thorin E; Peng J; Lavoie JL; Hu B; Stoyanova E; Cloutier G; Qi S; Wu T; Cameron M; Wu J
    J Biol Chem; 2012 Feb; 287(9):6819-29. PubMed ID: 22223652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
    Bowtell DD; Langdon WY
    Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.